Released Aug 5, 2010, after the close
10-Q filed Aug 5, 2010, 36 days after period end · 0000950123-10-073394
Q2 2010 · 10-Q
Revenue$1.14M$1.14M no prior Q2 2009 on file
Net Income-$10.04M-$10.04M no prior Q2 2009 on file
EPS Diluted$0.12$0.12 no prior Q2 2009 on file
Gross Profit$613,000—
Operating Income-$10,150,000—
Margins · derived
Gross margin53.7%
Operating margin-889.6%
Net margin-880.0%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR